New Zealand vs Republic of Korea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
New Zealand
0.0%
in 2024
Republic of Korea
0.0%
in 2024
New Zealand rank
167th
Republic of Korea rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- New Zealand
- Republic of Korea
How they compare
New Zealand currently reports 0.0% against 0.0% in Republic of Korea, a difference of 0.0%.
Across all 10 years both countries report, Republic of Korea has been ahead every year.
New Zealand ranks 167th and Republic of Korea ranks 167th of 246 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Republic of Korea |
| 2020s | 0.0% | 0.0% | 0.0% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, New Zealand or Republic of Korea?
- New Zealand, at 0.0% against 0.0% in Republic of Korea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between New Zealand and Republic of Korea?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Republic of Korea?
- 10 years are reported by both, from 2015 to 2024.
- How do New Zealand and Republic of Korea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- New Zealand ranks 167th and Republic of Korea ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.